Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CABA	CABALETTA BIO INC	$286.53M	-128.30%	-95.50%	-82.57%	-353.60%	0.22	5.79	N/A	N/A	N/A
NNOX	NANO-X IMAGING LTD	$35.84M	-94.30%	-81.20%	-154.49%	-258.00%	0.26	2.84	-337.50%	-747.20%	-765.61%
LRMR	LARIMAR THERAPEUTICS INC	$224.39M	-137.40%	-97.70%	-131.62%	-823.00%	0.30	4.70	N/A	N/A	N/A
MDWD	MEDIWOUND LTD	$157.76M	-47.20%	-24.30%	-40.25%	-53.50%	1.02	2.32	15.50%	-170.10%	-180.95%
ORGO	ORGANOGENESIS HOLDINGS INC	$155.70M	-44.70%	-20.80%	-10.13%	-9.20%	0.80	3.52	70.40%	-23.10%	-7.74%
PVLA	PALVELLA THERAPEUTICS INC	$1.85B	-47.80%	-38.30%	-21.80%	-242.00%	0.17	21.18	N/A	N/A	N/A
GLAS	GLASS HOUSE BRANDS INC	$319.75M	-68.50%	-16.40%	-14.33%	-11.60%	2.04	1.33	30.80%	-31.70%	-22.61%
FEMY	FEMASYS INC	$14.74M	-226.00%	-74.70%	-130.63%	-95.30%	2.05	2.14	60.90%	-534.30%	-477.34%
LTRN	LANTERN PHARMA INC	$9.09M	-456.40%	-184.30%	-435.83%	27,389.90%	-3.67	1.96	N/A	N/A	N/A
RPID	RAPID MICRO BIOSYSTEMS INC	$43.84M	-177.00%	-73.10%	-121.03%	-83.30%	2.29	2.55	5.50%	-145.60%	-138.66%
TLRY	TILRAY BRANDS INC	$483.27M	-10.30%	-7.40%	-6.31%	-9.90%	0.44	1.88	29.10%	-17.10%	-12.42%
MBOT	MICROBOT MEDICAL INC	$68.51M	-21.90%	-20.80%	-23.52%	-22.80%	0.06	18.56	-185.30%	-4,722.30%	-4,722.25%
SABS	SAB BIOTHERAPEUTICS INC	$243.84M	-6.70%	-6.10%	-5.54%	-6.60%	0.11	9.22	N/A	N/A	N/A
KRRO	KORRO BIO INC	$129.73M	-114.30%	-68.60%	-70.15%	-69.50%	0.58	9.55	100.00%	-4,477.10%	-4,441.86%
CMPS	COMPASS PATHWAYS PLC	$1.54B	-398.20%	-105.00%	-285.29%	299.90%	4.97	1.30	N/A	N/A	N/A
PFSA	PROFUSA INC	$775.23k	N/A	-1,731.10%	157.56%	468.20%	-1.04	0.03	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$431.12M	-147.20%	-103.20%	-98.22%	3,983.00%	1.68	8.98	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$3.33B	-44.00%	-41.70%	-32.87%	-58.30%	0.04	21.02	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$316.77M	-24.70%	-23.50%	-23.60%	-27.90%	0.05	37.17	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$5.93B	-69.60%	-62.50%	-73.28%	1,761.00%	0.16	7.27	N/A	N/A	N/A
ADIL	ADIAL PHARMACEUTICALS INC	$8.64M	N/A	-495.60%	-241.16%	3,653.60%	-0.75	5.63	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$245.58M	-42.80%	-40.60%	-39.55%	-78.60%	0.07	15.82	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$116.82M	-108.00%	-85.80%	-138.37%	-301.80%	0.35	4.52	100.00%	-7,724.00%	-7,723.97%
ONMD	ONEMEDNET CORP	$23.83M	N/A	-521.20%	251.99%	287.00%	-1.39	0.28	-68.80%	-584.20%	-581.87%
AVBP	ARRIVENT BIOPHARMA INC	$793.36M	-50.30%	-46.70%	-44.63%	-70.50%	0.08	14.16	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$53.39M	-1,625.90%	-101.30%	-159.50%	-130.10%	-50.24	3.15	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$254.07M	-33.20%	-27.80%	-33.72%	-351.60%	0.19	12.08	100.00%	-311.10%	-307.96%
KROS	KEROS THERAPEUTICS INC	$222.66M	-21.40%	-19.80%	-31.26%	-227.00%	0.10	21.96	100.00%	-553.90%	-573.44%
EYPT	EYEPOINT INC	$264.67M	-135.80%	-108.30%	-164.55%	-174.50%	0.37	4.50	41.80%	-10,994.70%	-10,988.67%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$172.01M	-70.20%	-51.50%	-78.13%	-59.30%	0.50	4.82	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$721.46M	-134.50%	-51.10%	-68.82%	-165.80%	1.79	1.38	N/A	N/A	N/A
VRCA	VERRICA PHARMACEUTICALS INC	$61.50M	-444.40%	-76.60%	-202.22%	-301.60%	7.36	1.45	85.90%	-102.80%	-90.53%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$236.51M	-46.90%	-42.20%	-56.02%	-106.70%	0.17	4.69	N/A	N/A	N/A
HELP	HELUS PHARMA INC	$650.83M	-77.20%	-69.70%	-70.72%	-909.70%	0.07	10.97	N/A	N/A	N/A
GRCE	GRACE THERAPEUTICS INC	$41.86M	-33.70%	-32.10%	-44.90%	2,230.00%	0.04	11.47	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$2.52B	-7.70%	-6.00%	-6.54%	-6.90%	0.30	14.57	100.00%	-54.70%	-54.75%
OCS	OCULIS HOLDING AG	$517.67M	-42.70%	-35.30%	-35.32%	-68.60%	0.14	8.35	100.00%	-6,604.80%	-6,552.71%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$437.37M	-45.60%	-43.30%	-38.20%	-123.80%	0.08	16.00	N/A	N/A	N/A
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$67.30M	N/A	-1,220.50%	239.87%	330.60%	-1.28	0.18	N/A	N/A	N/A
CGON	CG ONCOLOGY INC	$5.53B	-25.20%	-24.00%	-21.61%	-26.00%	0.06	22.22	-85.20%	-3,602.70%	-3,602.68%
VRDN	VIRIDIAN THERAPEUTICS INC	$2.06B	-61.30%	-46.00%	-35.93%	-50.50%	0.66	16.95	100.00%	-544.10%	-522.11%
TLSA	TIZIANA LIFE SCIENCES LTD	$131.35M	-924.30%	-161.80%	-6,444.41%	1,249.60%	220.06	0.76	N/A	N/A	N/A
MIST	MILESTONE PHARMACEUTICALS INC	$95.37M	-288.40%	-58.30%	-45.91%	-53.90%	8.97	8.13	98.00%	-3,585.60%	-3,124.16%
EDSA	EDESA BIOTECH INC	$27.43M	-124.20%	-105.70%	-160.04%	1,020.90%	0.44	2.76	N/A	N/A	N/A
MPLT	MAPLIGHT THERAPEUTICS INC	$365.23M	-98.60%	-60.30%	-65.84%	-74.40%	0.06	16.52	N/A	N/A	N/A
VKTX	VIKING THERAPEUTICS INC	$3.11B	-94.60%	-82.70%	-129.73%	-121.50%	0.28	4.72	N/A	N/A	N/A
TVRD	TVARDI THERAPEUTICS INC	$13.87M	-145.40%	-91.10%	-310.13%	1,654.30%	1.09	1.87	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$45.16M	-686.00%	-258.80%	-315.88%	1,117.10%	-6.18	3.47	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$182.56M	N/A	-88.10%	-127.67%	-205.70%	-2.88	3.32	100.00%	-395.20%	-395.46%
TNGX	TANGO THERAPEUTICS INC	$3.75B	-25.70%	-23.40%	-11.75%	-33.00%	0.05	50.82	100.00%	-229.90%	-230.03%
GPCR	STRUCTURE THERAPEUTICS INC	$1.59B	-16.90%	-16.10%	-15.75%	-23.50%	0.05	20.75	N/A	N/A	N/A
NGEN	NERVGEN PHARMA CORP	$173.45M	-1,061.20%	-168.30%	-358.61%	215.50%	4.22	1.23	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$2.07B	-50.40%	-38.30%	-47.90%	-300.40%	0.33	5.03	3.50%	-945.90%	-954.27%
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$885.96M	-83.20%	-58.50%	-48.07%	-195.50%	0.34	12.56	N/A	N/A	N/A
LBRX	LB PHARMACEUTICALS INC	$1.12B	-25.90%	-24.70%	-25.34%	-149.20%	0.09	15.08	N/A	N/A	N/A
SION	SIONNA THERAPEUTICS INC	$198.03M	-32.90%	-31.10%	-35.74%	-38.70%	0.07	20.05	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$194.44M	-48.40%	-46.60%	-57.71%	-65.90%	0.04	27.99	100.00%	-4,955.70%	-4,955.67%
NGNE	NEUROGENE INC	$431.45M	-45.10%	-41.00%	-49.86%	-69.80%	0.13	10.65	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$614.23M	-48.20%	-43.00%	-47.18%	-53.10%	0.13	8.86	N/A	N/A	N/A
CUE	CUE BIOPHARMA INC	$142.16M	-1,032.20%	-484.70%	-1,722.76%	-3,345.20%	12.29	1.26	100.00%	-435.80%	-434.15%
GTBP	GT BIOPHARMA INC	$11.73M	-657.30%	-464.50%	-611.63%	2,385.00%	0.62	2.61	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.67B	-57.80%	-47.30%	-51.43%	-57.40%	0.18	6.65	100.00%	-672.20%	-672.16%
MLYS	MINERALYS THERAPEUTICS INC	$1.86B	-58.00%	-54.10%	-53.90%	-71.10%	0.21	34.46	N/A	N/A	N/A
TENX	TENAX THERAPEUTICS INC	$59.88M	-61.50%	-57.40%	-57.10%	2,144.10%	0.07	15.07	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$4.58M	N/A	-622.30%	-3,426.48%	442.20%	10.32	1.12	N/A	N/A	N/A
SPRB	SPRUCE BIOSCIENCES INC	$115.97M	-123.50%	-90.30%	-53.93%	2,138.80%	0.23	9.23	N/A	N/A	N/A
CLPT	CLEARPOINT NEURO INC	$299.25M	-188.10%	-40.90%	-38.57%	-38.10%	7.05	4.75	62.60%	-81.80%	-69.73%
MSLE	SATELLOS BIOSCIENCE INC	$146.70M	N/A	N/A	N/A	N/A	0.10	11.22	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$853.48M	-49.10%	-45.60%	-34.76%	-64.30%	0.07	14.93	N/A	N/A	N/A
INBX	INHIBRX BIOSCIENCES INC	$1.28B	N/A	-83.50%	-97.19%	-90.50%	-3.91	5.07	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$106.83M	-53.40%	-49.10%	-57.43%	-59.50%	0.08	13.55	91.70%	-586.70%	-586.71%
TECX	TECTONIC THERAPEUTIC INC	$416.60M	-35.30%	-33.60%	-37.68%	-22,463.10%	0.06	22.29	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$154.34M	-38.70%	-34.70%	-42.20%	-44.30%	0.15	11.22	N/A	N/A	N/A
IVVD	INVIVYD INC	$190.41M	-59.70%	-49.00%	-57.14%	-422.50%	0.21	5.87	92.20%	-183.90%	-183.90%
IMNM	IMMUNOME INC	$2.00B	-50.60%	-46.90%	-48.02%	-320.90%	0.08	15.08	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$720.32M	-892.10%	-143.70%	1,566.17%	-5,803.90%	-13.98	0.95	N/A	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$259.99M	-85.00%	-56.80%	-71.32%	-102.30%	0.87	1.61	93.70%	-127.40%	-82.14%
MDCX	MEDICUS PHARMA LTD	$4.14M	N/A	-415.30%	-271.46%	-3,558.20%	-16.35	1.57	N/A	N/A	N/A
TYRA	TYRA BIOSCIENCES INC	$1.11B	-46.40%	-43.10%	-41.41%	-58.10%	0.08	14.91	N/A	N/A	N/A
CELC	CELCUITY INC	$3.09B	-350.80%	-41.50%	-27.55%	-26.50%	-65.80	8.93	N/A	N/A	N/A
ANNX	ANNEXON INC	$726.09M	-106.20%	-79.80%	-97.63%	-291.40%	0.32	5.53	N/A	N/A	N/A
NKTX	NKARTA INC	$150.41M	-39.60%	-30.50%	-37.35%	-29.40%	0.36	7.98	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$190.15M	-205.80%	-69.90%	-87.38%	-83.80%	1.64	7.90	N/A	N/A	N/A
BIOA	BIOAGE LABS INC	$255.65M	-29.00%	-27.10%	-24.94%	-61.30%	0.06	17.19	100.00%	-912.30%	-909.54%
CAPR	CAPRICOR THERAPEUTICS INC	$400.00M	-56.60%	-44.00%	-37.63%	-67.60%	0.50	7.35	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$2.86B	-64.30%	-50.30%	-55.08%	-119.40%	0.42	12.02	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$474.65M	N/A	-27.40%	-37.63%	-45.10%	-0.03	8.36	100.00%	-10,288.40%	-10,411.37%
IMCC	IM CANNABIS CORP	$739.05k	N/A	-58.30%	137.36%	-161.20%	-9.48	0.48	12.50%	-39.60%	-27.93%
VERA	VERA THERAPEUTICS INC	$1.93B	-84.10%	-66.80%	-81.37%	-81.00%	0.31	10.92	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$92.45M	-87.10%	-74.20%	-96.59%	-108.90%	0.24	5.71	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES INC	$618.73M	-50.40%	-40.10%	-39.90%	-642.30%	0.23	9.99	100.00%	-309.70%	-309.73%
CNSY	CERENOME INC	$13.21M	-394.20%	-151.40%	-477.14%	4,979.20%	1.57	1.37	100.00%	-620.70%	-620.18%
SLBT	SL SCIENCE HOLDING LTD	$857.96M	N/A	-5.30%	-162.64%	-5.40%	0.23	3.05	35.30%	-173.80%	-173.85%
CMMB	CHEMOMAB THERAPEUTICS LTD	$9.34M	-70.40%	-62.60%	-86.97%	-184.70%	0.18	6.41	N/A	N/A	N/A
BOLT	BOLT BIOTHERAPEUTICS INC	$8.25M	-126.20%	-54.70%	-88.49%	-54.30%	2.19	2.61	100.00%	-611.50%	-611.47%
CMND	CLEARMIND MEDICINE INC	$1.67M	-88.50%	-61.60%	-57.34%	-4,372.20%	0.31	4.31	N/A	N/A	N/A
EVAX	EVAXION A	$23.02M	-109.90%	-41.40%	-41.29%	-58.30%	1.03	5.06	100.00%	-115.50%	-89.56%
HIND	VYOME HOLDINGS INC	$13.83M	-198.70%	-130.70%	-145.50%	776.80%	0.26	4.37	52.30%	544.10%	538.19%
RVP	RETRACTABLE TECHNOLOGIES INC	$18.26M	-4.90%	-2.50%	-2.56%	-2.50%	0.95	4.93	-1.40%	-10.60%	-9.68%
SLXN	SILEXION THERAPEUTICS CORP	$978.61k	-563.10%	-201.70%	-5,232.22%	-3,594.70%	95.50	0.94	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	-3.31%	-4.41%	-12.70%	-72.42%	14.11x	4.88x	-11.01%	-10.03%	-8.07%	+80.04%	Strong Buy
Diagnostics & Research	50	+0.10%	+0.57%	+9.91%	+27.17%	11.79x	4.71x	-29.33%	+5.36%	+11.40%	+2.64%	Buy
Drug Manufacturers - General	20	-1.75%	+0.62%	+1.14%	+24.37%	39.28x	7.83x	+23.62%	+10.74%	+19.12%	+25.37%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.97%	-0.73%	-5.30%	-94.19%	-1.74x	2.35x	-1.68%	+1.60%	+7.12%	+194.41%	Buy
Healthcare Plans	10	-0.24%	+3.91%	-0.88%	+18.01%	55.82x	2.32x	+10.70%	+3.28%	+8.15%	+11.54%	Buy
Health Information Services	50	-0.34%	-0.87%	+0.40%	-44.85%	11.95x	4.03x	+7.12%	+4.01%	+9.09%	+17.05%	Buy
Medical Care Facilities	48	-0.09%	+1.43%	-0.27%	-53.67%	16.80x	5.73x	-42.74%	+7.27%	+14.52%	+13.50%	Buy
Medical Devices	132	-0.38%	+0.33%	-1.59%	-95.34%	22.66x	3.06x	-9.45%	+5.29%	+9.68%	+27.22%	Strong Buy
Medical Distribution	8	+0.84%	+3.87%	+3.55%	+23.59%	26.62x	-190.64x	-76.01%	+4.11%	+24.39%	+6.81%	Buy
Medical Instruments & Supplies	50	-0.46%	+1.98%	+2.84%	+3.00%	44.54x	3.37x	+8.63%	+7.24%	+11.01%	+14.77%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: C, Safety: C, Financials: A, and AI: B.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 91.3% over the past year, overperforming other healthcare stocks by 169 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -40.71% from Puma Biotechnology's current stock price of $10.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the #2 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 6, which is -21 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock lose -3.6% over the past year, overperforming other healthcare stocks by 74 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 52.8% from Bausch Health Companies's current stock price of $5.89.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #3 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 106.39% over the past year, overperforming other healthcare stocks by 184 percentage points.

Bioventus has an average 1 year price target of $16.00, an upside of 17.99% from Bioventus's current stock price of $13.56.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 79 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Conmed (NYSE:CNMD)

Conmed (NYSE:CNMD) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.25%. Conmed's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Conmed's dividend has not shown consistent growth over the last 10 years.

Conmed's dividend payout ratio of 10.8% indicates that its dividend yield is sustainable for the long-term.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 20.92%, which is 19 percentage points higher than the healthcare sector average of 2.25%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.52%, which is 9 percentage points higher than the healthcare sector average of 2.25%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.35% in the last day, and down -0.79% over the last week. Syndax Pharmaceuticals was the among the top losers in the healthcare sector, dropping -15.71% yesterday.

Syndax Pharmaceuticals shares are trading lower after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 142.57% in the past year. It has overperformed other stocks in the healthcare sector by 220 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 55.68% in the past year. It has overperformed other stocks in the healthcare sector by 133 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -53.56% in the past year. It has overperformed other stocks in the healthcare sector by 24 percentage points.

Are healthcare stocks a good buy now?

59.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.26% over the next year.

4.04% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.26% of healthcare stocks are rated B (Buy), 48.61% are rated C (Hold), 27.4% are rated D (Sell), and 6.69% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 30.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.